30 December 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021
Serafino Fazio1ABDEF, Paolo Bellavite2AE*, Elisabetta Zanolin3CD, Peter A. McCullough
4DE, Sergio Pandolfi5AD, Flora Affuso6ABF
DOI: 10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
Table 3 Mutually adjusted odds ratios and 95% confidence intervals for the association of considered variables with duration of symptoms in the whole sample.
| Variable* | Odds ratio** | 95% CI | p value |
|---|---|---|---|
| Age | 1.00 | 0.94–1.06 | 0.961 |
| Sex (F vs M) | 0.99 | 0.18–5.32 | 0.995 |
| Weight | 0.99 | 0.90–1.10 | 0.970 |
| BMI | 1.05 | 0.80–1.39 | 0.688 |
| Saturation at 1 visit | 0.67 | 0.41–1.09 | 0.405 |
| Treatment initiation | |||
| Hypertension (n=39) | 0.66 | 0.10–4.24 | 0.666 |
| Diabetes (n=18) | 0.37 | 0.038–3.53 | 0.388 |
| IHD (n=10) | 2.27 | 0.21–24.21 | 0.494 |
| Pleural pain (n=35) | |||
| * BMI – body mass index; IHD – ischemic heart disease. ** Odds ratio of the risk of duration of symptoms equal or longer than the median of duration of symptoms in the whole population (=8 days). , statistically significant results. | |||